SRPT
Sarepta Therapeutics Inc
Halal Rating :
Last Price
$118.04
Last updated:
Market Cap
-
7D Change
-0.33%
1 Year Change
-2.49%
Company Overview
Industries
Exchange
Next Earnings Date
Sarepta Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases. The company's primary focus is on Duchenne muscular dystrophy (DMD) and other rare genetic disorders. Their main revenue comes from the commercialization of RNA-targeted therapeutics and gene therapy products.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $467.17m | $444.98m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $362.93m | $363.63m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $413.46m | $378.56m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Sarepta Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.